Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Dele…
この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Dele…
この記事を読む
EGFR mutation is not a prognostic factor for CNS metastasis in curatively resected lung adenocarcinoma patients. Liu X e…
この記事を読む
Investigation on the survival implications of PD-L1 expression status in ALK- rearranged advanced non-small cell lung ca…
この記事を読む
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel. Bar-On YM et al.N Engl J Med. 2022 May 5;386(18):1712…
この記事を読む
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre,…
この記事を読む
Generalizability of immune checkpoint inhibitor trials to real-world patients with advanced non-small cell lung cancer. …
この記事を読む
IMpower150 Final Exploratory Analyses for Atezolizumab Plus Bevacizumab and Chemotherapy in Key NSCLC Patient Subgroups …
この記事を読む
Continuation of Lorlatinib in ALK-Positive NSCLC Beyond Progressive Disease. Ou SI et al.J Thorac Oncol. 2022 Apr;17(4):…
この記事を読む
Survival after surgery for clinical stage I non-small-cell lung cancer with interstitial pneumonia. Fukui M et al.Lung C…
この記事を読む
Nomogram Predicting Overall Survival Benefit of Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung C…